Metastatic breast cancer lung cancers adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Lung Neoplastic Cells, Circulating Tumor Cells, Cultured MCF-7 Cells Neoplastic Stem Cells Axilla Lymph Nodes Epithelial Cells

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases57

Breast Neoplasms Adenocarcinoma Lung Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Disease Progression Carcinoma, Ductal, Breast Bone Neoplasms Neoplasm Invasiveness Neoplastic Cells, Circulating Carcinoma Breast Neoplasms, Male Lymphatic Metastasis Mammary Neoplasms, Experimental Neoplasm Recurrence, Local Carcinoma, Lobular Carcinoma, Small Cell Stomach Neoplasms Pancreatic Neoplasms Breast Diseases Neutropenia Neoplasms, Hormone-Dependent Neoplasms Ovarian Neoplasms Colonic Neoplasms Prostatic Neoplasms Genetic Predisposition to Disease Carcinoma, Squamous Cell Esophageal Neoplasms Adenocarcinoma, Mucinous Liver Neoplasms Lung Diseases Small Cell Lung Carcinoma Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Ductal Carcinoma, Intraductal, Noninfiltrating Hematologic Diseases Cell Transformation, Neoplastic Brain Neoplasms Carcinoma, Pancreatic Ductal Inflammatory Breast Neoplasms Mammary Neoplasms, Animal Adenocarcinoma, Papillary Nausea Colorectal Neoplasms Endometrial Neoplasms Carcinoma, Large Cell Uterine Cervical Neoplasms Alopecia Neovascularization, Pathologic Neoplasms, Multiple Primary Soft Tissue Neoplasms Precancerous Conditions Carcinoma in Situ Barrett Esophagus Neoplasms, Second Primary Fatigue

Chemicals and Drugs71

Teniposide Receptor, erbB-2 Taxoids Paclitaxel Anthracyclines Antibodies, Monoclonal, Humanized Antineoplastic Agents Tumor Markers, Biological Receptors, Estrogen Fluorouracil Tamoxifen Deoxycytidine Cyclophosphamide Antineoplastic Agents, Phytogenic Bridged Compounds Epirubicin Antineoplastic Agents, Hormonal Receptors, Progesterone Antibodies, Monoclonal Vinblastine Doxorubicin Neoplasm Proteins Fluoxymesterone Quinazolines Thiotepa Aromatase Inhibitors Antibiotics, Antineoplastic Epothilones Antimetabolites, Antineoplastic Nitriles Mucin-1 RNA, Messenger Receptor, Epidermal Growth Factor Estrogen Antagonists DNA, Neoplasm Triazoles Maytansine Cisplatin Mitolactol Antigens, Neoplasm Mitoxantrone Estrogen Receptor Modulators RNA, Small Interfering Estrogens Fadrozole Estrogen Receptor alpha Carboplatin Megestrol Acetate Tumor Suppressor Protein p53 Aminoglutethimide Megestrol Carcinoembryonic Antigen Protein Kinase Inhibitors Estradiol Cancer Vaccines Methotrexate Granulocyte Colony-Stimulating Factor Toremifene Selective Estrogen Receptor Modulators Ki-67 Antigen BRCA2 Protein MicroRNAs BRCA1 Protein Tumor Suppressor Proteins RNA, Neoplasm Antigens, Tumor-Associated, Carbohydrate Furans Ketones Transcription Factors DNA-Binding Proteins Keratins

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Disease-Free Survival Drug Administration Schedule Prognosis Survival Analysis Neoplasm Staging Survival Rate Immunohistochemistry Retrospective Studies Chemotherapy, Adjuvant Kaplan-Meier Estimate Early Detection of Cancer Mammary Neoplasms, Experimental Combined Modality Therapy Risk Factors Follow-Up Studies Prospective Studies Infusions, Intravenous Reverse Transcriptase Polymerase Chain Reaction Clinical Trials as Topic Gene Expression Profiling Mammography Mastectomy Neoplasm Transplantation Case-Control Studies Clinical Trials, Phase III as Topic Xenograft Model Antitumor Assays Multivariate Analysis Sensitivity and Specificity Predictive Value of Tests Risk Assessment Tumor Burden Administration, Oral Risk In Situ Hybridization, Fluorescence Blotting, Western Transplantation, Heterologous Cohort Studies Proportional Hazards Models Tissue Array Analysis Immunoenzyme Techniques Incidence Oligonucleotide Array Sequence Analysis Odds Ratio Molecular Targeted Therapy Salvage Therapy Clinical Trials, Phase II as Topic Confidence Intervals Polymerase Chain Reaction Reproducibility of Results Drug Evaluation Maximum Tolerated Dose Registries Transfection Palliative Care Logistic Models Drug Screening Assays, Antitumor Feasibility Studies Randomized Controlled Trials as Topic Biopsy, Needle Remission Induction Questionnaires Neoadjuvant Therapy Breast Self-Examination Pilot Projects Tomography, X-Ray Computed SEER Program Positron-Emission Tomography Biopsy Flow Cytometry Hematopoietic Stem Cell Transplantation

Psychiatry and Psychology3

Smoking Breast Self-Examination Breast Feeding

Phenomena and Processes39

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, erbB-2 Dose-Response Relationship, Drug Postmenopause Time Factors Cell Proliferation Genetic Predisposition to Disease Menopause Sensitivity and Specificity Mutation Apoptosis Risk Cell Movement Signal Transduction Gene Amplification Premenopause Genes, BRCA1 Odds Ratio Cell Division Down-Regulation Up-Regulation Cell Survival Maximum Tolerated Dose Transfection Cell Growth Processes DNA Methylation Genotype Promoter Regions, Genetic RNA Interference Drug Synergism Gene Expression Polymorphism, Genetic Genes, BRCA2 Breast Feeding Gene Silencing Epithelial-Mesenchymal Transition Cell Cycle Genes, Tumor Suppressor

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science5

Survival Rate Incidence Registries Questionnaires SEER Program

Named Groups1

Health Care33

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Retrospective Studies Kaplan-Meier Estimate Risk Factors Follow-Up Studies Prospective Studies Clinical Trials as Topic Case-Control Studies Clinical Trials, Phase III as Topic Multivariate Analysis Sensitivity and Specificity Predictive Value of Tests Risk Assessment Risk Age Factors Cohort Studies Proportional Hazards Models Incidence Odds Ratio Clinical Trials, Phase II as Topic Confidence Intervals Reproducibility of Results Registries Palliative Care Logistic Models Feasibility Studies Randomized Controlled Trials as Topic Questionnaires Pilot Projects SEER Program

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Teniposide Breast Neoplasms Adenocarcinoma Lung Neoplasms Neoplasm Metastasis Receptor, erbB-2 Antineoplastic Combined Chemotherapy Protocols Breast Taxoids Paclitaxel Anthracyclines Antibodies, Monoclonal, Humanized Antineoplastic Agents Cell Line, Tumor Treatment Outcome Disease-Free Survival Tumor Markers, Biological Receptors, Estrogen Drug Administration Schedule Prognosis Survival Analysis Fluorouracil Tamoxifen Carcinoma, Non-Small-Cell Lung Disease Progression Gene Expression Regulation, Neoplastic Deoxycytidine Carcinoma, Ductal, Breast Neoplasm Staging Bone Neoplasms Lung Cyclophosphamide Antineoplastic Agents, Phytogenic Bridged Compounds Epirubicin Neoplasm Invasiveness Antineoplastic Agents, Hormonal Receptors, Progesterone Drug Resistance, Neoplasm Survival Rate Neoplastic Cells, Circulating Antibodies, Monoclonal Vinblastine Genes, erbB-2 Doxorubicin Immunohistochemistry Neoplasm Proteins Carcinoma Breast Neoplasms, Male Mice, Nude Retrospective Studies Fluoxymesterone Chemotherapy, Adjuvant Quinazolines Kaplan-Meier Estimate Thiotepa Early Detection of Cancer Aromatase Inhibitors Lymphatic Metastasis Mammary Neoplasms, Experimental Combined Modality Therapy Antibiotics, Antineoplastic Tumor Cells, Cultured Neoplasm Recurrence, Local Dose-Response Relationship, Drug Risk Factors Follow-Up Studies Epothilones Postmenopause Prospective Studies Infusions, Intravenous Carcinoma, Lobular Carcinoma, Small Cell Stomach Neoplasms Time Factors Reverse Transcriptase Polymerase Chain Reaction Pancreatic Neoplasms Antimetabolites, Antineoplastic Nitriles Clinical Trials as Topic Breast Diseases Cell Proliferation Neutropenia Gene Expression Profiling Mucin-1 Mammography RNA, Messenger Neoplasms, Hormone-Dependent Neoplasms Mastectomy Ovarian Neoplasms Receptor, Epidermal Growth Factor Estrogen Antagonists Colonic Neoplasms Neoplasm Transplantation Case-Control Studies Prostatic Neoplasms DNA, Neoplasm Genetic Predisposition to Disease Menopause

No FAQ available that match "metastatic breast cancer lung cancers adenocarcinoma"